Kenneth Mace

Mr. Ken Mace brings to Alzheon more than 20 years of senior finance and operations leadership in leading, building and advising biopharmaceutical companies; with extensive experience with developing business plans, financing strategies and financial modeling. Previously, Mr. Mace served as the Vice President of Finance, New Ventures at Flagship Pioneering, a venture capital firm that creates and grows first-in-category life science companies, where he supported 20+ new venture entities. Before Flagship Pioneering, Mr. Mace was Vice Director and Senior Project Manager, Group Planning and Special Projects, with F. Hoffman-La Roche Ltd., where he provided financial analysis in support of long-range business planning. Earlier, Mr. Mace was Vice President of Finance and Global Operations at mtm laboratories AG, an in-vitro diagnostics company. In this role, he was responsible for finance and sales operations and was the finance lead for the $230 million acquisition by Roche Diagnostics. Mr. Mace also held positions of increasing responsibility with life science companies ViaCell, Inc., Cytyc Corporation, and Boston Scientific Corporation.

Mr. Mace earned his MBA from Babson College and BS in Accounting and Finance from Roger Williams University.